Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$145.54 - $178.83 $9,751 - $11,981
67 Added 5.16%
1,365 $236,000
Q1 2024

May 10, 2024

SELL
$165.67 - $199.94 $8,614 - $10,396
-52 Reduced 3.85%
1,298 $219,000
Q4 2023

Feb 05, 2024

BUY
$151.44 - $200.09 $204,444 - $270,121
1,350 New
1,350 $266,000
Q1 2023

May 05, 2023

BUY
$145.48 - $175.02 $180,977 - $217,724
1,244 New
1,244 $207,000
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $173,126 - $222,099
-1,110 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$181.39 - $234.03 $201,342 - $259,773
1,110 New
1,110 $222,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Silver Oak Securities, Inc Portfolio

Follow Silver Oak Securities, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Oak Securities, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Silver Oak Securities, Inc with notifications on news.